{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:37:56Z","timestamp":1763156276554,"version":"3.33.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Frailty & Aging"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.14283\/jfa.2023.10","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T10:03:37Z","timestamp":1674727417000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Centrally Acting ACE Inhibitor Use and Physical Performance in Older Adults"],"prefix":"10.1016","volume":"12","author":[{"given":"Claudene J.","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.F.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Neptune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Abadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.14283\/jfa.2023.10_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acel.12601","article-title":"Molecular and physiological manifestations and measurement of aging in humans","volume":"16","author":"Khan","year":"2017","journal-title":"Aging Cell"},{"issue":"1","key":"10.14283\/jfa.2023.10_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2010.08.004","article-title":"The frail renin-angiotensin system","volume":"27","author":"Abadir","year":"2011","journal-title":"Clin Geriatr Med"},{"issue":"9","key":"10.14283\/jfa.2023.10_bib3","doi-asserted-by":"crossref","first-page":"127S","DOI":"10.1016\/j.amjhyper.2005.06.002","article-title":"Renin-angiotensin system modulation: the weight of evidence","volume":"18","author":"Brown","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.14283\/jfa.2023.10_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","article-title":"Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases","volume":"40","author":"Tan","year":"2018","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.14283\/jfa.2023.10_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ggi.13927","article-title":"Effect of renin-angiotensin system on senescence","volume":"20","author":"Mogi","year":"2020","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"10.14283\/jfa.2023.10_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1532-5415.2004.52265.x","article-title":"Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study","volume":"52","author":"Di Bari","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"9310","key":"10.14283\/jfa.2023.10_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","article-title":"Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study","volume":"359","author":"Onder","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.14283\/jfa.2023.10_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1503\/cmaj.061339","article-title":"Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial","volume":"177","author":"Sumukadas","year":"2007","journal-title":"CMAJ"},{"issue":"3","key":"10.14283\/jfa.2023.10_bib9","first-page":"97","article-title":"Polypharmacy issues in older adults","volume":"61","author":"Chiang-Hanisko","year":"2014","journal-title":"Hu Li Za Zhi"},{"issue":"1","key":"10.14283\/jfa.2023.10_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ageing\/afx127","article-title":"The effect of perindopril on postural instability in older people with a history of falls-a randomised controlled trial","volume":"47","author":"Sumukadas","year":"2018","journal-title":"Age Ageing"},{"issue":"6","key":"10.14283\/jfa.2023.10_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/gerona\/glt142","article-title":"Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial","volume":"69","author":"Sumukadas","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.14283\/jfa.2023.10_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jamda.2009.09.014","article-title":"ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study","volume":"11","author":"Cesari","year":"2010","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"10.14283\/jfa.2023.10_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jamda.2016.03.022","article-title":"Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors","volume":"17","author":"George","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.14283\/jfa.2023.10_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pmedr.2016.03.009","article-title":"The effects of antihypertensive medications on physical function","volume":"3","author":"Loprinzi","year":"2016","journal-title":"Prev Med Rep"},{"issue":"12","key":"10.14283\/jfa.2023.10_bib15","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/jgs.12029","article-title":"Statins, angiotensin-converting enzyme inhibitors, and physical performance in older women","volume":"60","author":"Gray","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.14283\/jfa.2023.10_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cmet.2010.09.011","article-title":"The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance","volume":"12","author":"Grobe","year":"2010","journal-title":"Cell Metab"},{"issue":"2","key":"10.14283\/jfa.2023.10_bib17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ije\/dyu067","article-title":"Cohort Profile: the Health and Retirement Study (HRS)","volume":"43","author":"Sonnega","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"10.14283\/jfa.2023.10_bib18","doi-asserted-by":"crossref","first-page":"i162","DOI":"10.1093\/geronb\/gbr048","article-title":"Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study","volume":"66","author":"Crimmins","year":"2011","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"347","key":"10.14283\/jfa.2023.10_bib19","first-page":"1","article-title":"Prescription Drug Use Among Adults Aged 40\u201379 in the United States and Canada","author":"Hales","year":"2019","journal-title":"NCHS Data Brief"},{"key":"10.14283\/jfa.2023.10_bib20","doi-asserted-by":"crossref","first-page":"586314","DOI":"10.3389\/fnins.2020.586314","article-title":"Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty","volume":"14","author":"Cosarderelioglu","year":"2020","journal-title":"Front Neurosci"},{"issue":"8","key":"10.14283\/jfa.2023.10_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/oxfordjournals.aje.a115957","article-title":"Peak expiratory flow rate and 5-year mortality in an elderly population","volume":"133","author":"Cook","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.14283\/jfa.2023.10_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/14756366.2011.622271","article-title":"The effect of angiotensin-converting enzyme inhibition by captopril on respiratory mechanics in healthy rats","volume":"27","author":"Rubini","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"10.14283\/jfa.2023.10_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1164\/rccm.201601-0094OC","article-title":"Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease","volume":"194","author":"Curtis","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.14283\/jfa.2023.10_bib24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/en.2003-0150","article-title":"Minireview: overview of the renin-angiotensin system\u2014an endocrine and paracrine system","volume":"144","author":"Lavoie","year":"2003","journal-title":"Endocrinology"},{"issue":"3A","key":"10.14283\/jfa.2023.10_bib25","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/0002-9343(91)90429-2","article-title":"Treatment of hypertension in the elderly: effects on blood pressure, heart rate, and physical fitness","volume":"90","author":"Leonetti","year":"1991","journal-title":"Am J Med"}],"container-title":["The Journal of Frailty & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:05:11Z","timestamp":1737338711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2260134124000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2260134124000768"],"URL":"https:\/\/doi.org\/10.14283\/jfa.2023.10","relation":{},"ISSN":["2260-1341"],"issn-type":[{"type":"print","value":"2260-1341"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centrally Acting ACE Inhibitor Use and Physical Performance in Older Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Frailty & Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jfa.2023.10","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}